Fosfomycin as a salvage therapy for treating urinary tract infections due to multidrug-resistant Escherichia coli

Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):689-690. doi: 10.1007/s10096-022-04412-9. Epub 2022 Feb 3.

Patrice Nordmann^{1

2

3

4}, Mustafa Sadek¹, Laurent Poirel^{5

6

7}, Trinad Chakraborty⁸

¹ Department of Medicine, Faculty of Science, Medical and Molecular Microbiology, University of Fribourg, Fribourg, Switzerland.
² INSERM European Unit (IAME), University of Fribourg, Fribourg, Switzerland.
³ Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.
⁴ Institute for Microbiology, University of Lausanne and University Hospital Centre, Lausanne, Switzerland.
⁵ Department of Medicine, Faculty of Science, Medical and Molecular Microbiology, University of Fribourg, Fribourg, Switzerland. laurent.poirel@unifr.ch.
⁶ INSERM European Unit (IAME), University of Fribourg, Fribourg, Switzerland. laurent.poirel@unifr.ch.
⁷ Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland. laurent.poirel@unifr.ch.
⁸ Institute of Medical Microbiology, and German Center for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Justus Liebig University Giessen, Schubertstrasse 81, 35392, Giessen, Germany.

No abstract available

Publication types